Literature DB >> 16204358

Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants.

C Hoecker1, M Nelle, B Beedgen, J Rengelshausen, O Linderkamp.   

Abstract

BACKGROUND: A single high loading dose of 25 mg/kg caffeine has been shown to be effective for the prevention of apnoea, but may result in considerable reductions in blood flow velocity (BFV) in cerebral and intestinal arteries.
OBJECTIVE: To assess the effects of two loading doses of 12.5 mg/kg caffeine given four hours apart on BFV in cerebral and intestinal arteries, left ventricular output (LVO), and plasma caffeine concentrations in preterm infants.
DESIGN: Sixteen preterm neonates of <34 weeks gestation were investigated one hour after the first oral dose and one, two, and 20 hours after the second dose by Doppler sonography.
RESULTS: The mean (SD) plasma caffeine concentrations were 31 (7) and 29 (7) mg/l at two and 20 hours respectively after the second dose. One hour after the first dose, none of the circulatory variables had changed significantly. One hour after the second caffeine dose, mean BFV in the internal carotid artery and anterior cerebral artery showed significant reductions of 17% and 19% (p = 0.01 and p = 0.003 respectively). BFV in the coeliac artery and superior mesenteric artery, LVO, PCO2, and respiratory rate had not changed significantly. Total vascular resistance, calculated as the ratio of mean blood pressure to LVO, had increased significantly one and two hours after the second dose (p = 0.049 and p = 0.023 respectively).
CONCLUSION: A divided high loading dose of 25 mg/kg caffeine given four hours apart had decreased BFV in cerebral arteries after the second dose, whereas BFV in intestinal arteries and LVO were not affected.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16204358      PMCID: PMC2672661          DOI: 10.1136/adc.2005.073866

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  34 in total

1.  Aminophylline increases cerebral metabolic rate and decreases anoxic survival in young mice.

Authors:  J H Thurston; R E Hauhard; J A Dirgo
Journal:  Science       Date:  1978-08-18       Impact factor: 47.728

2.  Xanthines and necrotising enterocolitis.

Authors:  R A Jones
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

3.  Xanthines and necrotising enterocolitis.

Authors:  M J Robinson; G S Clayden; M F Smith
Journal:  Arch Dis Child       Date:  1980-06       Impact factor: 3.791

4.  Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants.

Authors:  Christina Hoecker; Mathias Nelle; Johannes Poeschl; Bernd Beedgen; Otwin Linderkamp
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

5.  Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea.

Authors:  J Bauer; K Maier; O Linderkamp; R Hentschel
Journal:  Pediatrics       Date:  2001-04       Impact factor: 7.124

6.  Aminophylline reduces cerebral blood flow velocity in low-birth-weight infants.

Authors:  T S Rosenkrantz; W Oh
Journal:  Am J Dis Child       Date:  1984-05

7.  Neonatal apnea, xanthines, and necrotizing enterocolitis.

Authors:  J L Grosfeld; M C Dalsing; M Hull; T R Weber
Journal:  J Pediatr Surg       Date:  1983-02       Impact factor: 2.545

8.  Pharmacokinetic profile of caffeine in the premature newborn infant with apnea.

Authors:  J V Aranda; C E Cook; W Gorman; J M Collinge; P M Loughnan; E W Outerbridge; A Aldridge; A H Neims
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

9.  The effects of intermittent positive pressure ventilation on cerebral arterial and venous blood velocities in the newborn infant.

Authors:  F Cowan; M Thoresen
Journal:  Acta Paediatr Scand       Date:  1987-03

10.  Does caffeine affect cerebral blood flow in the preterm infant?

Authors:  F Van Bel; M Van de Bor; T Stijnen; J Baan; J H Ruys
Journal:  Acta Paediatr Scand       Date:  1989-03
View more
  7 in total

1.  Neonatal colour Doppler ultrasound study: normal values of abdominal blood flow velocities in the neonate during the first month of life.

Authors:  Patrizia Papacci; Carmen Giannantonio; Francesco Cota; Caterina Latella; Carla Maria Semeraro; Maria Fioretti; Mikael Ghennet Tesfagabir; Costantino Romagnoli
Journal:  Pediatr Radiol       Date:  2009-02-03

Review 2.  Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.

Authors:  Katherine Schoen; Tian Yu; Chris Stockmann; Michael G Spigarelli; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

Review 3.  Caffeine therapy in preterm infants.

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  World J Clin Pediatr       Date:  2015-11-08

4.  Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity.

Authors:  Nancy Abdel Salam Gomaa; Youssef A H Helmy; Sara Maher; Dina Hassanein; Asmaa Shuaib; Ahmed I Hegazy; Aliaa A Ali
Journal:  Clin Ophthalmol       Date:  2021-06-01

5.  Hemodynamic Effects on Systemic Blood Flow and Ductal Shunting Flow after Loading Dose of Intravenous Caffeine in Preterm Infants according to the Patency of Ductus Arteriosus.

Authors:  Jihye Hwang; Yu Seon Kim; Jeong Hee Shin; Byung Min Choi
Journal:  J Korean Med Sci       Date:  2018-01-22       Impact factor: 2.153

6.  The efficacy and safety of two different doses of caffeine in respiratory function of preterm infants.

Authors:  Fatemeh Faramarzi; Mohammadreza Shiran; Mohammadreza Rafati; Roya Farhadi; Ebrahim Salehifar; Maryam Nakhshab
Journal:  Caspian J Intern Med       Date:  2018

7.  Haemodynamic effects of prenatal caffeine on the cardiovascular transition in ventilated preterm lambs.

Authors:  Corinna Binder-Heschl; Kelly Crossley; Arjan Te Pas; Graeme Polglase; Douglas Blank; Valerie Zahra; Alison Moxham; Karyn Rodgers; Stuart Hooper
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.